The explosion of gene and cell therapies is a testament to the dedication and steadfastness of the leaders pushing the envelope of what’s possible in biology. As the first treatments gained approval in the last decade, the industry has been able to use the word “cure” as more than just a fantastical ambition. The cures have arrived, and these industry leaders are staunch believers in even greater potential down the line.
From innovators tackling the world’s toughest diseases to overseers of the thorny manufacturing and business side of gene and cell therapies, these leaders are spearheading a brand new facet of the industry and shaping its future.
Here are this year’s Cell and Gene Therapy Pioneers.
Dr. Eric Adler
“We have incredible foundational science, but now it’s our job to turn it into something that can actually help people.” Read more ➔
Dr. Aris Baras
“We are seeing tangible application of genetics to enhance drug target identification and optimize discovery and development.” Read more ➔
Bruce Lahn
“The most exciting thing in the life sciences is the rapid rise of genetic medicine as the third generation of pharmaceuticals.” Read more ➔
Benjamin Oakes
“Lead with honesty, not hype; don’t underestimate folks’ intelligence.” Read more ➔
Nia Tatsis
“Being the first in a new therapeutic area comes with responsibilities we don’t take lightly.” Read more ➔
Joe Truitt
“We are in the vanguard of gene insertion efforts to address very devastating disorders.” Read more ➔
Kristin Yarema
“We are no longer dreaming about but starting to see functional cures for terrible diseases.” Read more ➔
Heidi Zhang
“As we advance epigenetic editing therapies, we will uncover remarkable insights about this groundbreaking modality.” Read more ➔
